Cure My Disease

Don't miss your cure!

 Log in / Sign up

Light and touch therapies tested for COVID-19 recovery

NCT ID NCT06795841

Symptom relief Sponsor: Beni-Suef University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two therapies—low-level laser (light) therapy and myofascial release (a hands-on muscle technique)—against standard chest physiotherapy in 102 moderate COVID-19 patients in the ICU. All patients also received a 12-week home telerehabilitation program after discharge. The goal was to see if these treatments could reduce inflammation markers and improve breathing, strength, and fatigue.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
low-level laser therapy
What this could lead to
If successful, this could point toward a non-drug way to reduce inflammation and speed recovery in hospitalized COVID-19 patients.
What could go wrong
This is a small, completed trial with no phase designation, so results may not apply broadly. The outcomes are lab markers and functional tests, not survival or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

102 people

The number who actually took part.

Started

Jun 2020

Finished

Dec 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The eligibility criteria were as follows: * Patients aged from 45 to 60 years old. * Diagnosed by CT or PCR as positive COVID 19. * Moderate cases of COVID-19(According to CO-RADS Scale). * On low flow rate oxygen supply Exclusion Criteria: * Patients on Invasive Mechanical Ventilation * Hemodynamically Unstable with inotropic support * Septic Shock * ICU admission less than 24 h * physician termination of physiotherapy; * Fever with causes other than chest infection. * Severe electrolyte imbalance * Acute Venous Thromboembolism (VTE) without therapeutic anticoagulation for over 48 hours, * Unstable Atrial fibrillation , or Severe Tachycardia compared to baseline.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 disease

Contacts and locations

Locations

  • Faculty of Physical Therapy , Beni-Suef University

    Banī Suwayf, 62511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.